Results 31 to 40 of about 151,249 (259)

Advances in the Immunology and Genetics of Leprosy

open access: yesFrontiers in Immunology, 2020
Leprosy, a disease caused by the intracellular parasite Mycobacterium leprae or Mycobacterium lepromatosis, has affected humans for more than 4,000 years and is a stigmatized disease even now.
Zihao Mi, Hong Liu, Furen Zhang
doaj   +1 more source

Evaluation of the economic burden of leprosy among migrant and resident patients in Guangdong Province, China

open access: yesBMC Infectious Diseases, 2017
Background A lot of time and money was needed during the diagnosis and treatment process of leprosy, the delayed leprosy would also impair the labor capability of patients as well, and these put a heavy burden for the leprosy patients.
Mingzhou Xiong   +6 more
doaj   +1 more source

The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination [PDF]

open access: yes, 2012
Background: Neglected tropical diseases (NTDs) are a group of chronic parasitic diseases and related conditions that are the most common diseases among the 2·7 billion people globally living on less than US$2 per day.
A Alemu   +103 more
core   +2 more sources

Clustering of leprosy beyond the household level in a highly endemic setting on the Comoros, an observational study

open access: yesBMC Infectious Diseases, 2019
Background The island of Anjouan (Comoros) is highly endemic for leprosy with an annual incidence of 5–10/10,000. In May/June, 2015 single-dose Rifampicin post-exposure prophylaxis (SDR-PEP) was administered to 269 close contacts of 70 leprosy-patients ...
Nimer Ortuno-Gutierrez   +10 more
doaj   +1 more source

Leprosy in elderly and children among new cases – A 3-year retrospective study

open access: yesIndian Dermatology Online Journal, 2021
Background: Leprosy occurs in all age groups, with adults constituting the majority. However, leprosy in children always drew the attention of epidemiologists as a guide to transmission of leprosy.
Potharaju Arunraghav, Kallappa Herakal
doaj   +1 more source

Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts

open access: yesBMC Infectious Diseases, 2019
Background Leprosy is an ancient infectious disease with a global annual incidence that has plateaued above 200,000 new cases since over a decade. New strategies are required to overcome this stalemate.
Nimer Ortuno-Gutierrez   +13 more
doaj   +1 more source

Introducing leprosy post-exposure prophylaxis into the health systems of India, Nepal and Indonesia: a case study

open access: yesBMC Health Services Research, 2017
Background Leprosy has a wide range of clinical and socio-economic consequences. India, Indonesia and Nepal contribute significantly to the global leprosy burden. After integration, the health systems are pivotal in leprosy service delivery.
A. Tiwari   +6 more
doaj   +1 more source

EXPERIMENTAL STUDY OF SPECIFIC ACTIVITY OF 1,3-DIAZINON-4 COMPOUND PYaTdl DERIVATIVE IN VIVO

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2016
Aim. Study anti-leprosy activity of a 1.3-diazinon-4 compound derivative under the laboratory code PYaTd 1 on the model of intra-plantar infection of mice and evaluate the character of its antibacterial effect. Materials and methods.
S. A. Luzhnova   +5 more
doaj   +1 more source

The Story of a Village: A Case Study in Strategic Planning at Enyinndakurom, Ankaful, Central Region, Ghana [PDF]

open access: yes, 2019
The development of a strategic plan for an African village can seem a daunting task, especially if the village is one created from diverse beginnings and different cultural origins, where ethnicity, language and custom are not homogenous.
Redington, Wynette
core   +2 more sources

Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial

open access: yesJournal of Dermatological Treatment, 2023
Background Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia (AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate grades of androgenetic alopecia is not established.
Mithinkumar Balasundaram   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy